Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Metastatic Colorectal Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The mCRC market report provides current treatment practices, emerging drugs, mCRC market share of the individual therapies, current and forecasted mCRC market Size from ... Read More
-
Oncolytic virus cancer therapy - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • ... Read More
-
Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology And Market Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The mCSPC market report provides current treatment practices, emerging drugs, mCSPC market share of the individual therapies, current and forecasted mCSPC market Size ... Read More
-
Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030
... market size is expected t-reach USD 1,735.36 million by 2030 according t-a new study by Polaris Market Research. The report “Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, ... Read More
-
Radiopharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Type: Diagnostic; Therapeutic 2) By Application: Oncology; Cardiology; Neuroendocrinology; Nephrology; Musculoskeletal; Respiratory; Others 3) By End-User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes Covering: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE); IBA Group
... market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies. Understand how the market is ... Read More
-
Fallopian tube cancer - Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Cell Therapy And Gene Therapy Markets
... Information presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and competitive summary of leading providers: Cell and Gene Therapy Market Summary by Product Segment, 2021-2031 ($ millions) ... Read More
-
Europe Breast Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Insight, Growth, Impact of COVID-19, Company Analysis
... most typical cause of cancer-related mortality among women in Europe. It is more prevalent in European countries due to its modernized lifestyle; late pregnancies, high intake of alcohol because of these factors breast cancer incidence ... Read More
-
Intratumoral Cancer Therapy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis
... the highest cause of death; with 19,292,789 new cancer cases were diagnosed and around 9,958,133 cancer death happened in the year 2020. Nevertheless, over the past years, the treatment paradigm of cancer has transformed with ... Read More
-
China Oncology Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis
... areas, with patients experiencing a significant health burden. Hence, the cancer drugs industry is the fastest-growing central therapeutic area in China’s pharmaceutical market. In particular, the increasingly challenging treatment of complex, severe cancerous diseases through ... Read More
-
Metastatic Colorectal Cancer - Epidemiology Forecast - 2032
... France, and United Kingdom), and Japan. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2019-2032 Metastatic Colorectal Cancer mCRC Understanding The DelveInsight’s mCRC epidemiology report gives ... Read More
-
Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032
... Italy, France, and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Disease Understanding ... Read More
-
Colombia Gastric Cancer Drugs Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation: Colombia Gastric Cancer Drugs Market, By Type (Adenocarcinoma, ... Read More
-
Adult Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis
... cost-effective strategies available in public health today. Each year, vaccine-preventable diseases kill thousands of adults across the world. Adult immunization includes the administration of licensed vaccines provided to patients aged 18 years and older for ... Read More
-
Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes)
... Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes) The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; ... Read More
-
Cervical Cancer - Epidemiology Forecast to 2030
... uterus (Mayo Clinic, 2021). All women are at risk for cervical cancer. It occurs most often in women ages 30 years and older (Centers for Disease Control and Prevention, 2021). Long-lasting infection with certain types ... Read More
-
India Immuno-Oncology Drugs Market, by Drug Type (Immune Checkpoint Inhibitors (Nivolumab, Atezolimumab, Pembrolizumab, Durvalumab), Monoclonal Antibodies (Rituximab, Trastazumab, Bevacizumab , Nimotuzumab, Pertuzumab, Ado-Trastuzumab Emtansine ), and Cancer Vaccines (Gardasil, Cervarix), by Cancer Type (Lung Cancer, Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity ... Read More
-
Global Cancer Survivorship Care Growth Opportunities
... States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (EHRs) or cancer treatment systems for cancer survivors. The use of patient-reported outcomes ... Read More
-
Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitors and CTLA-4 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma and other application): Global Opportunity Analysis and Industry Forecast, 2021-2030
... checkpoint inhibitors market was valued at $29,803.71 million in 2020, and is projected to reach $1,40,890.10 million by 2030, registering a CAGR of 16.8% from 2021 to 2030 Checkpoint inhibitor is a type of drug ... Read More
-
Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027
... Anticoagulant Drug Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2021-2027. Peptides are a specific ... Read More
-
Global Exosome Research Products Market Size study, by Application (Cancer Applications, Non-Cancer Applications), by Products & Services (Kits and Reagents, Instruments, Services), by End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories) and Regional Forecasts 2021-2027
... Testing Laboratories) and Regional Forecasts 2021-2027 Global Exosome Research Products Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % ... Read More
-
Lymphedema Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type {Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures [Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)], Debulking Procedures [Surgical Debulking, Liposuction, and Others], and Others}, and End-User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... (LVA) and Vascularized Lymph Node Transfer (VLNT)], Debulking Procedures [Surgical Debulking, Liposuction, and Others], and Others}, and End-User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market is projected to reach US$ 11.58 ... Read More
-
North America Cancer Vaccines Market- Growth, Trends, and Forecast(2022 - 2027)
... growth of the market are the increasing number of cancer cases, rising investments and government funding in the development of cancer vaccines, and technological developments in cancer vaccines. The incidence of cancer is increasing every ... Read More
-
Asia-Pacific Acute Myeloid Leukemia Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... number of clinical trials into new therapies for leukemia patients. In Japan, approximately 4,500 patients are being diagnosed with AML every year, according to a 2018 report by Astellas Pharma Inc. Moreover, the survey has ... Read More
-
Cancer Cachexia Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing measures enforced globally. ... Read More
Research Assistance
